| |
 |
|
Class Information
Number: 424/464
Name: Drug, bio-affecting and body treating compositions > Preparations characterized by special physical form > Tablets, lozenges, or pills
Description: Subject matter in which the special physical form is a tablet, lozenge or pill.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7291347 |
Succinate salt of O-desmethyl-venlafaxine |
Nov. 6, 2007 |
| 7282221 |
Antiviral product, use and formulation thereof |
Oct. 16, 2007 |
| 7276253 |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
Oct. 2, 2007 |
| 7276250 |
Sustained release formulations of oxymorphone |
Oct. 2, 2007 |
| 7276249 |
Nanoparticulate fibrate formulations |
Oct. 2, 2007 |
| 7273624 |
Stable dosage forms containing ubiquinones |
Sep. 25, 2007 |
| 7273623 |
Process for preparing tannate tablet, capsule or other solid dosage forms |
Sep. 25, 2007 |
| 7273521 |
Method of producing granulated calcium carbonate/calcium phosphate composite materials with very high calcium to phosphate mole ratios |
Sep. 25, 2007 |
| 7270831 |
Orally administrable opioid formulations having extended duration of effect |
Sep. 18, 2007 |
| 7265151 |
Treatment of neurotic disorders |
Sep. 4, 2007 |
| 7258872 |
Chromone enteric release formulation |
Aug. 21, 2007 |
| 7258871 |
Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
Aug. 21, 2007 |
| 7255878 |
Stable benzimidazole formulation |
Aug. 14, 2007 |
| 7255876 |
Composition comprises sustained-release fine particles and manufacturing method thereof |
Aug. 14, 2007 |
| 7250176 |
Method of treating a bacterial infection |
Jul. 31, 2007 |
| 7244451 |
Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
Jul. 17, 2007 |
| 7241805 |
Modified release formulations of a bupropion salt |
Jul. 10, 2007 |
| 7241458 |
Antiviral compositions |
Jul. 10, 2007 |
| 7235258 |
Sustained-release formulations for treating CNS-mediated disorders |
Jun. 26, 2007 |
| 7232576 |
Throat lozenge for the treatment of Streptococcus Group A |
Jun. 19, 2007 |
| 7232572 |
Methods of treating rosacea |
Jun. 19, 2007 |
| 7230019 |
Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides |
Jun. 12, 2007 |
| 7229644 |
Pharmaceutical formulations of modafinil |
Jun. 12, 2007 |
| 7229643 |
Oral 2-methyl-thieno-benzodiazepine formulation |
Jun. 12, 2007 |
| 7229642 |
Amino acid modulated extended release dosage form |
Jun. 12, 2007 |
| 7229640 |
Paroxetine controlled release compositions |
Jun. 12, 2007 |
| 7229637 |
Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
Jun. 12, 2007 |
| 7226620 |
Directly compressible tricalcium phosphate |
Jun. 5, 2007 |
| 7226618 |
Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
Jun. 5, 2007 |
| 7226614 |
Tablet comprising cetirizine and pseudoephedrine |
Jun. 5, 2007 |
| 7217431 |
Controlled agglomeration |
May. 15, 2007 |
| 7217430 |
Compositions and methods of treatment comprising amoxicillin and potassium clavulanate with xanthan |
May. 15, 2007 |
| 7217428 |
Drug delivery apparatus utilizing cantilever |
May. 15, 2007 |
| 7214387 |
Sustained release formulations of metformin |
May. 8, 2007 |
| 7214386 |
Method for the treatment and prevention of overweight in mammals |
May. 8, 2007 |
| 7214381 |
Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
May. 8, 2007 |
| 7211267 |
Methods of treating acne |
May. 1, 2007 |
| 7202087 |
Anticoagulant composition |
Apr. 10, 2007 |
| 7201922 |
Orodispersible solid pharmaceutical form |
Apr. 10, 2007 |
| 7201913 |
Oral formulations for anti-tumor compounds |
Apr. 10, 2007 |
| 7198802 |
Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
Apr. 3, 2007 |
| 7198795 |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
Apr. 3, 2007 |
| 7196064 |
Compositions of plant carbohydrates as dietary supplements |
Mar. 27, 2007 |
| 7195779 |
Storage stable thyroxine active drug formulations and methods for their production |
Mar. 27, 2007 |
| 7195769 |
Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
Mar. 27, 2007 |
| 7192608 |
Method of manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules |
Mar. 20, 2007 |
| 7192588 |
Vaccine composition and method of using the same |
Mar. 20, 2007 |
| 7189415 |
Rapidly disintegrable pharmaceutical composition |
Mar. 13, 2007 |
| RE39502 |
Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids |
Mar. 6, 2007 |
| 7186418 |
Composition and use of RAR antagonists for promoting chondrogenesis |
Mar. 6, 2007 |
|
|
|
